SAADH, M.J. 2022. SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19. International Journal of Applied Pharmaceutics. 14, 6 (Nov. 2022), 18–20. DOI:https://doi.org/10.22159/ijap.2022v14i6.46015.